Rac-Belinostat
CAS: 414864-00-9
Ref. TM-T1852
5mg | 46.00 € | ||
10mg | 67.00 € | ||
25mg | 95.00 € | ||
50mg | 142.00 € | ||
100mg | 202.00 € | ||
200mg | 325.00 € | ||
500mg | 540.00 € | ||
1ml*10 (DMSO) | 73.00 € |
Product Information
- NSC726630, PXD101, PX-105684
- 2-Propenamide, N-hydroxy-3-[3-[(phenylamino)sulfonyl]phenyl]-
- 2-propenamide, N-hydroxy-3-[3-[(phenylamino)sulfonyl]phenyl]-, (2E)-
- Belinostat
- N-Hydroxy-3-(3-phenylsulfamoylphenyl)acrylamide
- N-Hydroxy-3-[3-[(phenylamino)sulfonyl]phenyl]-2-propenamide
- Pxd101
Rac-Belinostat (PX-105684) is a novel hydroxamic acid-type histone deacetylase (HDAC) inhibitor with antineoplastic activity. Belinostat targets HDAC enzymes, thereby inhibiting tumor cell proliferation, inducing apoptosis, promoting cellular differentiation, and inhibiting angiogenesis. This agent may sensitize drug-resistant tumor cells to other antineoplastic agents, possibly through a mechanism involving the down-regulation of thymidylate synthase.
Chemical properties
Technical inquiry about: TM-T1852 Rac-Belinostat
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.